Literature DB >> 17249304

Photodynamic therapy.

Mollie A MacCormack1.   

Abstract

ALA-PDT is a safe, well-tolerated, and effective treatment for many dermatologic conditions. Current data most strongly support its use in the treatment of actinic damage, but further investigation into alternative uses continues. Current efficacy is limited primarily by the depth of penetration of the photosensitizing agent and the activating light source. Even with this limitation, the potential applications of PDT are numerous. As new technology is developed to overcome current restraints, the future of PDT is wide open.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17249304     DOI: 10.1016/j.yadr.2006.09.008

Source DB:  PubMed          Journal:  Adv Dermatol        ISSN: 0882-0880


  12 in total

1.  Antitumor effects evaluation of a novel porphyrin derivative in photodynamic therapy.

Authors:  Jian-Wei Li; Zhong-Ming Wu; Davor Magetic; Li-Jun Zhang; Zhi-Long Chen
Journal:  Tumour Biol       Date:  2015-07-08

2.  Noninvasive fluorescence monitoring of protoporphyrin IX production and clinical outcomes in actinic keratoses following short-contact application of 5-aminolevulinate.

Authors:  Christine B Warren; Sara Lohser; Lauren C Wene; Brian W Pogue; Philip L Bailin; Edward V Maytin
Journal:  J Biomed Opt       Date:  2010 Sep-Oct       Impact factor: 3.170

3.  In vivo photoactivation without "light": use of Cherenkov radiation to overcome the penetration limit of light.

Authors:  Chongzhao Ran; Zhaoda Zhang; Jacob Hooker; Anna Moore
Journal:  Mol Imaging Biol       Date:  2012-04       Impact factor: 3.488

4.  Techniques for fluorescence detection of protoporphyrin IX in skin cancers associated with photodynamic therapy.

Authors:  Kishore R Rollakanti; Stephen C Kanick; Scott C Davis; Brian W Pogue; Edward V Maytin
Journal:  Photonics Lasers Med       Date:  2013-11-01

5.  Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo.

Authors:  Sanjay Anand; Golara Honari; Tayyaba Hasan; Paul Elson; Edward V Maytin
Journal:  Clin Cancer Res       Date:  2009-05-15       Impact factor: 12.531

6.  Synthesis and antitumor activity evaluation of a novel porphyrin derivative for photodynamic therapy in vitro and in vivo.

Authors:  Li-Jun Zhang; Yi-Jia Yan; Ping-Yong Liao; Davor Margetic; Li Wang; Zhi-Long Chen
Journal:  Tumour Biol       Date:  2015-12-11

7.  Blue light versus red light for photodynamic therapy of basal cell carcinoma in patients with Gorlin syndrome: A bilaterally controlled comparison study.

Authors:  Edward V Maytin; Urvashi Kaw; Muneeb Ilyas; Judith A Mack; Bo Hu
Journal:  Photodiagnosis Photodyn Ther       Date:  2018-02-19       Impact factor: 3.631

8.  Iron Chelators and Exogenic Photosensitizers. Synergy through Oxidative Stress Gene Expression.

Authors:  Anna Mrozek-Wilczkiewicz; Katarzyna Malarz; Marzena Rams-Baron; Maciej Serda; Daniela Bauer; Franz-Peter Montforts; Alicja Ratuszna; Thomas Burley; Jaroslaw Polanski; Robert Musiol
Journal:  J Cancer       Date:  2017-07-05       Impact factor: 4.207

9.  Use of photodynamic therapy and acitretin in generalized eruptive keratoacanthoma of Grzybowski.

Authors:  Stephanie Mlacker; Urvashi Kaw; Edward V Maytin
Journal:  JAAD Case Rep       Date:  2017-09-08

10.  Possibility for the Conjugated Use of Photodynamic Therapy and Electrosurgical Devices.

Authors:  Francisco de Assis Martins Gomes Rego Filho; Romualdo Arthur Alencar Caldas; Cristina Kurachi; Vanderlei Salvador Bagnato; Maria Tereza de Araujo
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.